Breaking News
If housing prices had simply followed income growth since 1970
According to INSEE data, France is now channeling 57.2% of its GDP through government spending
Power is moving eastwards and westerners are talking about how great it is...
Agricultural commodities are now breaking out decisively from nearly 20-year resistance.
Top Tech News
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.
Breakthrough cancer drug could be astronomical in price
"It is a revolutionary treatment," said Dr. Prakash Satwani, a pediatric hematologist at NewYork-Presbyterian/Columbia University Medical Center, noting that the therapy can help some leukemia patients with no other options. But, he added, "the price will be phenomenal."
"From what we're hearing, this will be a quantum leap more expensive than other cancer drugs," said Leonard Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center in New York.
Switzerland-based Novartis hasn't announced a price for the medicine, but British health authorities have said a price of $649,000 for a one-time treatment would be justified, given the significant benefits.
The cancer therapy was unanimously approved by a Food and Drug Administration advisory committee in July, and its approval seems all but certain.